Publications by authors named "Gilbert Wagener"

Claim this Profile
L
Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial.
Manuel Toledo, Christian Brandt, Pier Paolo Quarato, Anne-Liv Schulz, Jody M Cleveland, Gilbert Wagener

Epilepsy Behav· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.
Elinor Ben-Menachem, Michel Baulac, Seung Bong Hong, Jody M Cleveland, Christoph Reichel, Gilbert Wagener

Epilepsy Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects.
Zhaoyang Li, Marjie L Hard, Grit Andersen, Günther Pabst, Gilbert Wagener

Int J Clin Pharmacol Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.
Mary P McGowan, Jean-Claude Tardif, Richard Ceska, Lesley J Burgess, Handrean Soran, Gilbert Wagener

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial.
Maartje E Visser, Gilbert Wagener, Brenda F Baker, Richard S Geary, Joanne M Donovan

Eur Heart J· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Luis M Ruilope, Bridget-Anne Kirwan, Sophie de Brouwer, Nicolas Danchin, Keith A A Fox, Gilbert Wagener

J Hypertens· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study.
Guiseppe Mancia, Luis Ruilope, Christopher Palmer, Morris Brown, Alain Castaigne, Gilbert Wagener

Blood Press· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
Jacobus Lubsen, Gilbert Wagener, Bridget-Anne Kirwan, Sophie de Brouwer, Philip A Poole-Wilson

J Hypertens· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
Peter W de Leeuw, Luis M Ruilope, Christopher R Palmer, Morris J Brown, Alain Castaigne, Gilbert Wagener

Arch Intern Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
Philip A Poole-Wilson, Jacobus Lubsen, Bridget-Anne Kirwan, Fred J van Dalen, Gilbert Wagener

Lancet· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension.
Emilio Kuschnir, Mario Bendersky, Jorge Resk, Maria Silva Pañart, Luiz Guzman, Gilbert Wagener

J Cardiovasc Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
Giuseppe Mancia, Morris Brown, Alain Castaigne, Peter de Leeuw, Christopher R Palmer, Gilbert Wagener

Hypertension· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis